26 August 2014 - Deborah Wilkes
Archived
Valeant Pharmaceuticals International has acquired a portfolio of dermatology products and several specialty pharmaceuticals from Canada's Valeo Pharma in a deal worth US$25.3 million.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.